News | February 17, 2021
Steady quarter with margin improvement for Glenmark: ICICI Securities
India business grew 11.8% YoY vs mid-single digit industry growth.
India business grew 11.8% YoY vs mid-single digit industry growth.
The jump in profit is due to the better performance of the API business.
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Be One is a 100% Ayurvedic health and wellness supplement.
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
Subscribe To Our Newsletter & Stay Updated
